| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/16/2012 | US20120041056 Nucleic acids specifically binding with human factor vii/viia and uses thereof |
| 02/16/2012 | US20120041055 Composite polynucleic acid therapeutics |
| 02/16/2012 | US20120041054 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction |
| 02/16/2012 | US20120041052 Compositions and Methods to Treat Muscular & Cardiovascular Disorders |
| 02/16/2012 | US20120041051 Compositions And Methods For Inhibiting Expression Of MIG-12 Gene |
| 02/16/2012 | US20120041045 Use of pharmaceutical compositions containing mesembrenone |
| 02/16/2012 | US20120041044 Process for the preparation of carvedilol and its enantiomers |
| 02/16/2012 | US20120041035 Levamlodipine compound pharmaceutical composition |
| 02/16/2012 | US20120041032 Metalloprotein inhibitors |
| 02/16/2012 | US20120041025 Dihydrolipoic Acid Derivatives Comprising Nitric Oxide and Therapeutic Uses Thereof |
| 02/16/2012 | US20120041004 Fused pyrimidine-dione derivatives as trpai modulators |
| 02/16/2012 | US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 02/16/2012 | US20120040993 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/16/2012 | US20120040992 Oligooxopiperazines and methods of making and using them |
| 02/16/2012 | US20120040991 3-azabicyclo [4.1.0] heptanes used as orexin antagonists |
| 02/16/2012 | US20120040990 Indol-3-y-carbonyl-piperidin and piperazin-derivatives |
| 02/16/2012 | US20120040988 DERIVATIVES OF 6,7-DIHYDRO-3H-OXAZOLO[3,4-a]PYRAZINE-5,8-DIONE |
| 02/16/2012 | US20120040985 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity |
| 02/16/2012 | US20120040984 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/16/2012 | US20120040983 Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof |
| 02/16/2012 | US20120040964 N-substituted piperidines and their use as pharmaceuticals |
| 02/16/2012 | US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 02/16/2012 | US20120040956 Inhibitors of hif-1 protein accumulation |
| 02/16/2012 | US20120040954 Novel anti-inflammatory agents |
| 02/16/2012 | US20120040952 Azetidines as histamine h3 receptor antagonists |
| 02/16/2012 | US20120040951 Heteroaryl compounds useful as raf kinase inhibitors |
| 02/16/2012 | US20120040941 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases |
| 02/16/2012 | US20120040935 Compositions useful as inhibitors of voltage-gated ion channels |
| 02/16/2012 | US20120040934 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/16/2012 | US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 02/16/2012 | US20120040923 Stable s-adenosyl-l-methionine |
| 02/16/2012 | US20120040906 Protein targets in disease |
| 02/16/2012 | US20120040903 Method for treating dyspnea associated with acute heart failure |
| 02/16/2012 | US20120040902 Method of treating dyspnea associated with acute heart failure |
| 02/16/2012 | US20120040897 Novel derivatives of acyl cyanopyrrolidines |
| 02/16/2012 | US20120040892 Methods and Compositions for the Treatment of Heart Failure and Other Disorders |
| 02/16/2012 | US20120040886 Analogues of Neuropeptide Y Having Proline Substitution At Position 34 |
| 02/16/2012 | US20120040885 Analogues of Neuropeptide Y Having At Least One Synthetic Amino Acid Substitution |
| 02/16/2012 | US20120040884 Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration |
| 02/16/2012 | US20120040025 Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention |
| 02/16/2012 | US20120040024 Methods and compositions for enhancing survivability of cells, tissues, organs and organisms |
| 02/16/2012 | US20120040012 Therapeutic stem cell nutrient composition and uses thereof |
| 02/16/2012 | US20120039987 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof |
| 02/16/2012 | US20120039985 Dendritic cell modulation in post-ischemic wounds |
| 02/16/2012 | US20120039952 Compositions, methods & systems for respiratory delivery of two or more active agents |
| 02/16/2012 | US20120039946 Immunopotentiating composition and process for producing same |
| 02/16/2012 | US20120039911 Cd93 or use of soluble fragment thereof |
| 02/16/2012 | US20120039896 Method for inhibiting cellular activation by insulin-like growth factor-1 |
| 02/16/2012 | US20120039895 Phosphorycholine conjugates and corresponding antibodies |
| 02/16/2012 | US20120039884 Compositions and methods for treating cardiovascular disease |
| 02/16/2012 | US20120039883 Detection and diagnosis of inflammatory disorders |
| 02/16/2012 | US20120039882 Vascular Disease Therapies |
| 02/16/2012 | US20120039873 Antibodies against monocyte chemotactic proteins |
| 02/16/2012 | US20120039857 Systems and methods for cardiac tissue repair |
| 02/16/2012 | US20120039855 Fibrin based scaffold, preparation and use thereof |
| 02/16/2012 | US20120039852 Lactobacillus rhamnosus ncc4007, a probiotic mixture and weight control |
| 02/16/2012 | US20120039851 Use of androgens for vascular regeneration and endothelial repair |
| 02/16/2012 | US20120039844 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation |
| 02/16/2012 | US20120039839 Hypoxia Induced Mitogenic Factor |
| 02/16/2012 | US20120039810 Aptamer-containing compositions and methods for targeting e-selectin |
| 02/16/2012 | US20120039801 SPARC binding peptides and uses thereof |
| 02/16/2012 | CA2807858A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 02/16/2012 | CA2807359A1 Inhibitor of casein kinase 1.delta. and casein kinase 1.epsilon. |
| 02/15/2012 | EP2418279A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 02/15/2012 | EP2418272A1 New revascularization cells derived from mononuclear cells, and method of inducing differentiation thereof |
| 02/15/2012 | EP2417985A1 Mitochondrial function-improving agent |
| 02/15/2012 | EP2417943A1 Drug-delivery endovascular stent and method for treating restenosis |
| 02/15/2012 | EP2417130A2 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof |
| 02/15/2012 | EP2417121A1 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |
| 02/15/2012 | EP2417115A1 Inhibitors of fatty acid amide hydrolase |
| 02/15/2012 | EP2417112A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof |
| 02/15/2012 | EP2417110A2 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4]non-1-en-4-one (irbesartan) |
| 02/15/2012 | EP2416777A1 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives |
| 02/15/2012 | EP2416776A2 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease |
| 02/15/2012 | EP2213666B1 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application |
| 02/15/2012 | EP2170831B1 Benzazepine derivatives useful as vasopressin antagonists |
| 02/15/2012 | EP2062575B1 Adhesive preparation comprising desglymidodrine |
| 02/15/2012 | EP1831199B1 MMP inhibitors |
| 02/15/2012 | EP1797077B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 02/15/2012 | EP1661907B1 Method of preparing cardio myopeptidin |
| 02/15/2012 | EP1601362B1 Use of diazoxide in the treatment of ischemia retinae |
| 02/15/2012 | EP1581239B1 Early use of an extract of red vine leaves |
| 02/15/2012 | EP1381432B1 HSA-free formulations of interferon-beta |
| 02/15/2012 | CN1918127B 具有引入了取代或无取代氨基的4-吡啶基烷硫基的环状化合物 The introduction of a cyclic compound having a substituted or unsubstituted 4-pyridyl amino alkylthio |
| 02/15/2012 | CN1847228B 奥扎格雷鸟氨酸盐及其注射剂型 Orszag Thunderbird acid salts and injectable forms |
| 02/15/2012 | CN102355905A Stroke-generated angiogenesis enhancers and uses thereof |
| 02/15/2012 | CN102355903A A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment |
| 02/15/2012 | CN102355897A Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug |
| 02/15/2012 | CN102351918A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 02/15/2012 | CN102351880A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
| 02/15/2012 | CN102351878A Isoxazole derivatives as well as preparation method and application thereof |
| 02/15/2012 | CN102351877A Thiophene derivative, its preparation method and its application |
| 02/15/2012 | CN102351874A New erigeroster compound with medicinal activity |
| 02/15/2012 | CN102351853A Azilsartan medoxomil compound, preparation method and medicinal composition thereof |
| 02/15/2012 | CN102351812A Methanesulfonic acid cinepazide crystal form III and preparation method thereof |
| 02/15/2012 | CN102351791A Cyanoisoquinoline compounds capable of making hypoxia inducible factor (HIF) stable |
| 02/15/2012 | CN102351784A Benidipine hydrochloride crystal form and application thereof |
| 02/15/2012 | CN102351732A Nuclear receptor binding agents |
| 02/15/2012 | CN102351705A Propylgallate compound and pharmaceutical composition thereof |
| 02/15/2012 | CN102349985A Traditional Chinese medicine composition for treating chronic arrhythmias |